A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)
Crossref DOI link: https://doi.org/10.1007/s00520-016-3404-y
Published Online: 2016-09-09
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schloss, Janet M.
Colosimo, Maree
Airey, Caroline
Masci, Paul
Linnane, Anthony W.
Vitetta, Luis
License valid from 2016-09-09